{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:29Z","timestamp":1756902149286,"version":"3.44.0"},"reference-count":63,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Care coordination for children and youth with special health care needs and medical complexity (CYSHCN-CMC), especially medication management, is difficult for providers, parents\/caregivers, and \u00adpatients. This report describes the creation of a clinical pharmacotherapy practice in a pediatric long-term care facility (pLTCF), application of standard operating procedures to guide comprehensive medication management (CMM), and establishment of a collaborative practice agreement (CPA) to guide drug therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>In a prospective case series, 102 patients characterized as CYSHCN-CMC were included in this pLTCF quality improvement project during a 9-month period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Pharmacists identified, prevented, or resolved 1355 drug therapy problems (DTP) with an average of 13 interventions per patient. The patients averaged 9.5 complex chronic medical conditions with a \u00admedian length of stay of 2815 days (7.7 years). The most common medications discontinued due to pharmacist assessment and recommendation included diphenhydramine, albuterol, sodium phosphate enema, ipratropium, and metoclopramide. The average number of medications per patient was reduced from 23 to 20. A pharmacoeconomic analysis of 244 of the interventions revealed a monthly direct cost savings of $44,304 ($434 per patient per month) and monthly cost avoidance of $48,835 ($479 per patient per month). Twenty-eight ED visits\/admissions and 61 clinic and urgent care visits were avoided. Hospital \u00adreadmissions were reduced by 44%. Pharmacist recommendations had a 98% acceptance rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Use of a CPA to conduct CMM in CYSHCN-CMC decreased medication burden, resolved, and prevented adverse events, reduced health care-related costs, reduced hospital readmissions and was well-accepted and implemented collaboratively with pLTCF providers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5863\/1551-6776-29.2.119","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T17:22:18Z","timestamp":1712596938000},"page":"119-129","source":"Crossref","is-referenced-by-count":0,"title":["Medication Management Through Collaborative Practice for Children With Medical Complexity: A Prospective Case Series"],"prefix":"10.5863","volume":"29","author":[{"given":"Jena","family":"Quinn","sequence":"first","affiliation":[{"name":"Perfecting Peds (JQ, HMB, EW), Haddon Heights, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Monk","family":"Bodenstab","sequence":"additional","affiliation":[{"name":"Perfecting Peds (JQ, HMB, EW), Haddon Heights, NJ;"},{"name":"Medical Affairs (HMB), Sobi, Waltham, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Wo","sequence":"additional","affiliation":[{"name":"Perfecting Peds (JQ, HMB, EW), Haddon Heights, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Parrish","sequence":"additional","affiliation":[{"name":"College of Medicine (RHP), Mercer University, Columbus, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"issue":"6","key":"2024040817220924700_i2331-348X-29-2-119-b01","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1542\/peds.2012-0175","article-title":"Patterns and costs of health care use of children with medical complexity","volume":"130","author":"Cohen","year":"2012","journal-title":"Pediatrics"},{"issue":"suppl 3","key":"2024040817220924700_i2331-348X-29-2-119-b02","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1542\/peds.2017-1284E","article-title":"Status complexicus? The emergence of pediatric complex care","volume":"141","author":"Cohen","year":"2018","journal-title":"Pediatrics"},{"issue":"11","key":"2024040817220924700_i2331-348X-29-2-119-b03","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archpediatrics.2011.172","article-title":"A national profile of caregiver challenges among more medically complex children with special health care needs","volume":"165","author":"Kuo","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"2024040817220924700_i2331-348X-29-2-119-b04","doi-asserted-by":"crossref","first-page":"e20163021","DOI":"10.1542\/peds.2016-3021","article-title":"Recognition and management of medical complexity","volume":"138","author":"Kuo","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b05","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/josh.13132","article-title":"Care coordination for children with special health care needs: a scoping review to inform strategies for students with traumatic brain injuries","volume":"92","author":"Davies","year":"2022","journal-title":"J Sch Health"},{"key":"2024040817220924700_i2331-348X-29-2-119-b06","article-title":"Clinical care coordination in medically complex pediatric cases: results from the national survey of children with special health care needs","volume":"6","author":"Hofacer","year":"2019","journal-title":"Glob Pediatr Health"},{"issue":"suppl 3","key":"2024040817220924700_i2331-348X-29-2-119-b07","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1542\/peds.2017-1284G","article-title":"Care coordination for children with medical complexity: whose care is it, anyway?","volume":"141","author":"Kuo","year":"2018","journal-title":"Pediatrics"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b08","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/pop.2018.0094","article-title":"Unmet need for care coordination among children with special health care needs","volume":"22","author":"Miller","year":"2019","journal-title":"Popul Health Manag"},{"key":"2024040817220924700_i2331-348X-29-2-119-b09","article-title":"The influence of care coordination on patients with special health care needs in a pediatric residency continuity clinic","volume":"6","author":"Moeenuddin","year":"2019","journal-title":"Glob Pediatr Health"},{"issue":"13","key":"2024040817220924700_i2331-348X-29-2-119-b10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/0009922820941206","article-title":"Children with special needs: Social determinants of health and care coordination","volume":"59","author":"Pankewicz","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b11","first-page":"197","article-title":"Care coordination for children with special needs in Medicaid: lessons from Medicare","volume":"24","author":"Stewart","year":"2018","journal-title":"Am J Manag Care"},{"issue":"suppl 4","key":"2024040817220924700_i2331-348X-29-2-119-b12","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1542\/peds.2009-1255O","article-title":"Care coordination for CSHCN: associations with family-provider relations and family\/child outcomes","volume":"124","author":"Turchi","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"2024040817220924700_i2331-348X-29-2-119-b13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1377\/hlthaff.2014.0828","article-title":"Children with medical complexity and Medicaid: spending and cost savings","volume":"33","author":"Berry","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b14","doi-asserted-by":"crossref","first-page":"e20161581","DOI":"10.1542\/peds.2016-1581","article-title":"Families\u2019 priorities regarding hospital-to-home transitions for children with medical complexity","volume":"139","author":"Leyenaar","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"2024040817220924700_i2331-348X-29-2-119-b15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10995-018-2540-z","article-title":"Patient-centered medical home and receipt of Part C early intervention among young CSHCN and developmental disabilities versus delays: NS-CSHCN 2009\u20132010","volume":"22","author":"Ross","year":"2018","journal-title":"Matern Child Health J"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10995-017-2389-6","article-title":"How well is the medical home working for latino and black children?","volume":"22","author":"Guerrero","year":"2018","journal-title":"Matern Child Health J"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b17","doi-asserted-by":"crossref","first-page":"e2021050400","DOI":"10.1542\/peds.2021-050400","article-title":"Telemedicine for children with medical complexity: a randomized clinical trial","volume":"148","author":"Mosquera","year":"2021","journal-title":"Pediatrics"},{"issue":"12","key":"2024040817220924700_i2331-348X-29-2-119-b18","first-page":"135","article-title":"Developing future clinical pharmacy leaders in the interprofessional care of children with special health care needs and medical complexity (CSHCN-CMC) in a Pediatric Pulmonary Center","volume":"6","author":"Hobart","year":"2019","journal-title":"Children (Basel)"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b19","first-page":"58","article-title":"Creating a pharmacotherapy collaborative practice network to manage medications for children and youth: A population health perspective","volume":"6","author":"Parrish","year":"2019","journal-title":"Children (Basel)"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b20","first-page":"2):205","article-title":"Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980\u20131997","volume":"106","author":"Feudtner","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b21","first-page":"250","article-title":"Hospital admission medication reconciliation in medically complex children: an observational study","volume":"95","author":"Stone","year":"2010","journal-title":"Arch Dis Child"},{"issue":"5","key":"2024040817220924700_i2331-348X-29-2-119-b22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.japh.2022.04.005","article-title":"Identifying opportunities for pediatric medication therapy management in children with medical complexity","volume":"62","author":"Marquez","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1542\/peds.111.3.617","article-title":"Hospital-reported medical errors in children","volume":"111","author":"Slonim","year":"2003","journal-title":"Pediatrics"},{"issue":"16","key":"2024040817220924700_i2331-348X-29-2-119-b24","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpeds.2007.09.054","article-title":"Risk factors in preventable adverse drug events in pediatric outpatients","volume":"152","author":"Zandieh","year":"2008","journal-title":"J Pediatr"},{"issue":"6","key":"2024040817220924700_i2331-348X-29-2-119-b26","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1542\/peds.2013-3060","article-title":"Adverse drug event-related emergency department visits associated with complex chronic conditions","volume":"133","author":"Feinstein","year":"2014","journal-title":"Pediatrics"},{"issue":"8","key":"2024040817220924700_i2331-348X-29-2-119-b27","doi-asserted-by":"crossref","first-page":"e2122818","DOI":"10.1001\/jamanetworkopen.2021.22818","article-title":"Complexity of medication regimens for children with neurological impairment","volume":"4","author":"Feinstein","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b28","first-page":"62","article-title":"Perceived versus demonstrated understanding of the complex medications of medically complex children","volume":"26","author":"Blackmer","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"10","key":"2024040817220924700_i2331-348X-29-2-119-b29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/pds.3843","article-title":"The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients","volume":"24","author":"Feinstein","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b30","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1542\/peds.2014-2015","article-title":"Potential drug-drug interactions in infant, child, and adolescent patients in children\u2019s hospitals","volume":"135","author":"Feinstein","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"2024040817220924700_i2331-348X-29-2-119-b31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/pharmaceutics13071014","article-title":"Accuracy of dose administered to children using off-labelled or unlicensed oral dosage forms","volume":"13","author":"Binson","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024040817220924700_i2331-348X-29-2-119-b32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jpeds.2022.10.012","article-title":"Making polypharmacy safer for children with medical complexity","volume":"254","author":"Feinstein","year":"2023","journal-title":"J Pediatr"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1574884712666170317161935","article-title":"Pediatric off-label and unlicensed drug use and its implications","volume":"12","author":"Gore","year":"2017","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/hpeds.2013-0094","article-title":"Hospital readmission in children with complex chronic conditions discharged from subacute care","volume":"4","author":"Jurgens","year":"2014","journal-title":"Hosp Pediatr"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ppul.21536","article-title":"Hospital readmissions for newly discharged pediatric home mechanical ventilation patients","volume":"47","author":"Kun","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"2024040817220924700_i2331-348X-29-2-119-b36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2011.122","article-title":"Hospital utilization and characteristics of patients experiencing recurrent readmissions within children\u2019s hospitals","volume":"305","author":"Berry","year":"2011","journal-title":"Jama"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.japh.2020.11.009","article-title":"Economic impact of pharmacist interventions in pediatric ambulatory care clinics","volume":"61","author":"Yung","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"10","key":"2024040817220924700_i2331-348X-29-2-119-b38","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2024040817220924700_i2331-348X-29-2-119-b39","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics, Classification of Diseases, Functioning, and Disability, ICD-10-CM International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Accessed February 14, 2024. https:\/\/www.cdc.gov\/nchs\/icd\/icd10cm_browsertool.htm."},{"issue":"9","key":"2024040817220924700_i2331-348X-29-2-119-b40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ajhp\/58.9.784","article-title":"Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model","volume":"58","author":"Nesbit","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"2024040817220924700_i2331-348X-29-2-119-b41","unstructured":"Year to date average billed charges for inpatient, observation, and emergency department visits. Accessed May 1, 2023. https:\/\/www.childrenshospitals.org\/content\/analytics\/product-program\/pediatric-health-information-system"},{"key":"2024040817220924700_i2331-348X-29-2-119-b42","doi-asserted-by":"crossref","DOI":"10.37573\/9781585285112","volume-title":"Building A Successful Ambulatory Care Practice: A Complete Guide for Pharmacists","author":"Kliethermes","year":"2019","edition":"2nd ed"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pharmacy4010005","article-title":"Establishment of pediatric medication therapy management: a proposed model","volume":"4","author":"Benavides","year":"2016","journal-title":"Pharmacy (Basel)"},{"issue":"5","key":"2024040817220924700_i2331-348X-29-2-119-b44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ijpp\/riac037","article-title":"Impact of pharmacist medication review for paediatric patients: an observational study","volume":"30","author":"Solano","year":"2022","journal-title":"Int J Pharm Pract"},{"key":"2024040817220924700_i2331-348X-29-2-119-b45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/CIA.S216705","article-title":"Medication regimen complexity in 8 Australian residential aged care facilities: impact of age, length of stay, comorbidity, frailty, and dependence in activities of daily living","volume":"14","author":"Chen","year":"2019","journal-title":"Clin Interv Aging"},{"key":"2024040817220924700_i2331-348X-29-2-119-b46","unstructured":"FDA Drug Safety Communication: FDA warns of possible harm from exceeding recommended dose of over-the-counter sodium phosphate products to treat constipation. 2014. Accessed March 23, 2023. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-possible-harm-exceeding-recommended-dose-over-counter-sodium#:\u223c:text=Changes%20in%20blood%20electrolyte%20levels,these%20products%20in%2024%20hours"},{"key":"2024040817220924700_i2331-348X-29-2-119-b47","unstructured":"FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs. Rockville, MD: 2009. Accessed Fecbruary 14, 2024. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/metoclopramide-information"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/10781552211068139","article-title":"Clinical and economic impact of pharmacists\u2019 intervention on care of pediatric hematology and oncology patients","volume":"29","author":"Kim","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"2024040817220924700_i2331-348X-29-2-119-b49","unstructured":"Occupational and wage statistics\n          . Accessed August 8, 2023. https:\/\/www.bls.gov\/oes\/tables.htm"},{"key":"2024040817220924700_i2331-348X-29-2-119-b50","unstructured":"Hospital readmissions reduction program (HRRP)\n          . 2023. Accessed 27 October 2022. https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/Readmissions-Reduction-Program"},{"issue":"15","key":"2024040817220924700_i2331-348X-29-2-119-b51","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJMp1201268","article-title":"Medicare\u2019s readmissions-reduction program\u2013a positive alternative","volume":"366","author":"Berenson","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCOUTCOMES.111.000101","article-title":"Hospital strategies associated with 30-day readmission rates for patients with heart failure","volume":"6","author":"Bradley","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"2024040817220924700_i2331-348X-29-2-119-b53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11606-014-3105-5","article-title":"Hospital strategy uptake and reductions in unplanned readmission rates for patients with heart failure: a prospective study","volume":"30","author":"Bradley","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"17","key":"2024040817220924700_i2331-348X-29-2-119-b54","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"2024040817220924700_i2331-348X-29-2-119-b55","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCHEARTFAILURE.112.967406","article-title":"National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry","volume":"5","author":"Kociol","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"4","key":"2024040817220924700_i2331-348X-29-2-119-b56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jhq.12058","article-title":"Ohio Children\u2019s Hospitals\u2019 solutions for patient safety: a framework for pediatric patient safety improvement","volume":"38","author":"Lyren","year":"2016","journal-title":"J Healthc Qual"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b57","doi-asserted-by":"crossref","first-page":"e20181958","DOI":"10.1542\/peds.2018-1958","article-title":"Trends in pediatric hospitalizations and readmissions: 2010\u20132016","volume":"143","author":"Bucholz","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"2024040817220924700_i2331-348X-29-2-119-b58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.2010-0910","article-title":"Children with medical complexity: an emerging population for clinical and research initiatives","volume":"127","author":"Cohen","year":"2011","journal-title":"Pediatrics"},{"issue":"16","key":"2024040817220924700_i2331-348X-29-2-119-b59","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1503\/cmaj.141036","article-title":"Responding to the rising number of children living with complex chronic conditions","volume":"186","author":"Cohen","year":"2014","journal-title":"CMAJ"},{"issue":"7","key":"2024040817220924700_i2331-348X-29-2-119-b60","first-page":"82","article-title":"Pharmacist involvement in population health management for a pediatric managed Medicaid accountable care organization","volume":"6","author":"Kuhn","year":"2019","journal-title":"Children (Basel)"},{"issue":"9","key":"2024040817220924700_i2331-348X-29-2-119-b61","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/ppul.25554","article-title":"Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic","volume":"56","author":"Burrus","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"2024040817220924700_i2331-348X-29-2-119-b62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pedhc.2022.09.008","article-title":"Changes in use and access to care for children and youth with special health care needs during the COVID-19 pandemic","volume":"37","author":"Gigli","year":"2023","journal-title":"J Pediatr Health Care"},{"issue":"1","key":"2024040817220924700_i2331-348X-29-2-119-b63","doi-asserted-by":"crossref","first-page":"e0245368","DOI":"10.1371\/journal.pone.0245368","article-title":"Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital","volume":"16","author":"Murali","year":"2021","journal-title":"PLoS One"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/2\/119\/3354492\/i2331-348x-29-2-119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/2\/119\/3354492\/i2331-348x-29-2-119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:42:05Z","timestamp":1738780925000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/2\/article-p119.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.2.119","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}